Blood Volume as a new functional image-based biomarker of progression in metastatic renal cell carcinoma

Blood Volume as a new functional image-based biomarker of progression in metastatic renal cell carcinoma

Abstract RECIST v1.1 has limitations in evaluating progression. We assessed Dynamic Constrast Enhanced Computed Tomography (DCE-CT) identified Blood Volume (BV) for the evaluation of progressive disease (PD) in patients with metastatic renal cell carcinoma (mRCC). BV was quantified prospectively at...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aska Drljevic-Nielsen, Finn Rasmussen, Jill Rachel Mains, Kennet Thorup, Frede Donskov
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/7f96e8cb32084215b1cde863c1ebe68b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares